Dexamfetamine Sulfate

硫酸右苯丙胺

Report date: 2025/12/26 17:54:08
NME

Base Information

Drug NameDexamfetamine Sulfate
Drug Alias NameDextroamphetamine sulfateDEXEDRINESpansule
ClassificationSmall molecules
Mechanisms of ActionAdrenergic receptors agonists
TargetsAdrenergic receptors
Therapy Area/IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorNarcolepsy
Global Approved IndicationsAttention Deficit Disorder with HyperactivityNarcolepsy
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved DateN/A
Country/TerritoryUnited StatesGermanyEU +[4] 
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaApproved
Originator CompaniesVallon Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesWaymade BvGoethe UniversityImpax Laboratories Inc
Inactive CompaniesN/A
Active IndicationsAttention Deficit Disorder with HyperactivityDepressive Disorder, MajorNarcolepsy
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A